These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recent progress in fragment-based lead discovery. Schulz MN; Hubbard RE Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685 [TBL] [Abstract][Full Text] [Related]
4. Two 'Golden Ratio' indices in fragment-based drug discovery. Orita M; Ohno K; Niimi T Drug Discov Today; 2009 Mar; 14(5-6):321-8. PubMed ID: 19028598 [TBL] [Abstract][Full Text] [Related]
5. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
6. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads. Bergsdorf C; Ottl J Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747 [TBL] [Abstract][Full Text] [Related]